Femme Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
In postmenopausal women with overactive bladder: (1) To investigate a dose-related reduction, in average number of daily micturitions after 8 weeks of treatment with L 000796568 (375, 125, or 50 mg once daily), compared with placebo. (2) To evaluate the safety and tolerability of daily treatment with L-000796568 (375, 125, or 50 mg/d).
Critère d'inclusion
- Overative Bladder